Atea Pharmaceuticals, Inc.
AVIR • NASDAQ
Atea Pharmaceuticals, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jean-Pierre Sommadossi, with a market cap of $407.9M.
CEOJean-Pierre Sommadossi
Next Earnings
Upcoming earnings announcement for Atea Pharmaceuticals, Inc.
Date
Monday, May 11, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.57
Earnings History
Past 12 earnings reports for Atea Pharmaceuticals, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 5, 2026 | Q4 2025 | -$0.57Est: -$0.48 | -18.7% | - | — |  10-K |
| Nov 12, 2025 | Q3 2025 | -$0.53Est: -$0.43 | -23.3% | - | — | 10-Q |
| Aug 7, 2025 | Q2 2025 | -$0.44Est: -$0.43 | -2.3% | - | — | 10-Q |
| May 12, 2025 | Q1 2025 | -$0.40Est: -$0.41 | +2.4% | - | — | 10-Q |
| Mar 6, 2025 | Q4 2024 | -$0.40Est: -$0.29 | -37.9% | - | — | 10-K |
| Nov 7, 2024 | Q3 2024 | -$0.37Est: -$0.49 | +24.5% | - | — | 10-Q |
| Aug 7, 2024 | Q2 2024 | -$0.48Est: -$0.76 | +36.8% | - | — | 10-Q |
| May 14, 2024 | Q1 2024 | -$0.75Est: -$0.61 | -23.0% | - | — | 10-Q |
| Feb 28, 2024 | Q4 2023 | -$0.47Est: -$0.50 | +6.0% | - | — | 10-K |
| Nov 8, 2023 | Q3 2023 | -$0.40Est: -$0.48 | +16.7% | - | — | — |
| Aug 8, 2023 | Q2 2023 | -$0.34Est: -$0.47 | +27.7% | - | — | 10-Q |
| May 8, 2023 | Q1 2023 | -$0.43Est: -$0.48 | +10.4% | - | — | — |